Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

FiscalNote Holdings (NOTE) Research & Development: 2021-2025

Historic Research & Development for FiscalNote Holdings (NOTE) over the last 4 years, with Sep 2025 value amounting to $2.1 million.

  • FiscalNote Holdings' Research & Development fell 35.97% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 25.85%. This contributed to the annual value of $12.8 million for FY2024, which is 29.46% down from last year.
  • According to the latest figures from Q3 2025, FiscalNote Holdings' Research & Development is $2.1 million, which was down 8.20% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, FiscalNote Holdings' Research & Development registered a high of $6.4 million during Q3 2021, and its lowest value of $2.1 million during Q3 2025.
  • Over the past 3 years, FiscalNote Holdings' median Research & Development value was $3.2 million (recorded in 2024), while the average stood at $3.5 million.
  • In the last 5 years, FiscalNote Holdings' Research & Development climbed by 18.97% in 2023 and then tumbled by 35.97% in 2025.
  • Quarterly analysis of 5 years shows FiscalNote Holdings' Research & Development stood at $6.3 million in 2021, then declined by 16.51% to $5.3 million in 2022, then declined by 24.20% to $4.0 million in 2023, then decreased by 27.96% to $2.9 million in 2024, then slumped by 35.97% to $2.1 million in 2025.
  • Its Research & Development stands at $2.1 million for Q3 2025, versus $2.3 million for Q2 2025 and $3.1 million for Q1 2025.